Allogenica

Lyon, France

Allogenica develops allogenic CAR-T cells using donor stem cells for cancer treatment.

$2.7M raised

Mar 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Allogenica raised?

Allogenica has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in March 2025.

Who are Allogenica's investors?

Allogenica's investors include France 2030.

Where is Allogenica headquartered?

Allogenica is headquartered in Lyon, France.

What does Allogenica do?

Allogenica develops allogenic CAR-T cells using donor stem cells for cancer treatment.

What stage is Allogenica at?

Allogenica is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 19, 2025.

MLA

"Allogenica — Funding & Investors." VCBacked, March 19, 2025, https://www.vcbacked.co/company/allogenica. Accessed July 2, 2026.

APA

VCBacked. (2025). Allogenica — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/allogenica

Wikipedia (cite web)

{{cite web |title=Allogenica — Funding & Investors |url=https://www.vcbacked.co/company/allogenica |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 19, 2025.